FogPharma lands $107m Series C
FogPharma, a biopharmaceutical company, has raised $107 million in Series C financing.
FogPharma, a biopharmaceutical company, has raised $107 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination